Bill > HR7407

This bill, titled the "Prohibiting Tianeptine and Other Dangerous Products Act of 2026," aims to strengthen regulations around dietary supplements by amending the Federal Food, Drug, and Cosmetic Act. Specifically, it introduces new prohibited acts, meaning actions that are against the law. These include introducing or selling products marketed as dietary supplements that don't actually meet the legal definition of a dietary supplement, and also prohibits the sale of dietary supplements that were made with the help of individuals who have been debarred, meaning they are banned from participating in certain activities related to drug or food production. The bill also updates import rules and seizure authorities to include these new prohibited acts, allowing for the exclusion of improperly marketed or produced supplements from the country and for their seizure if they violate these new provisions. The Federal Food, Drug, and Cosmetic Act is the primary law that governs the safety and labeling of food, drugs, and cosmetics in the United States.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/7407/all-info